Skip to main content
. Author manuscript; available in PMC: 2016 Jul 21.
Published in final edited form as: Cell Rep. 2015 Jul 9;12(3):449–461. doi: 10.1016/j.celrep.2015.06.023

Figure 2. Interactions between UBE3A and SK2 and SK2 ubiquitination in hippocampal membrane fractions from WT and AS mice.

Figure 2

(A) Localization of UBE3A (green) and SK2 (red) in dendritic spines along apical dendrites of CA1 pyramidal neurons from a WT mouse (arrowheads indicate clear co-localization). Left panel, scale bar=20 μm. Right panel, scale bar=5 μm.

(B) Interactions between UBE3A and SK2 in hippocampal P2 fractions. Upper panel, Western blot analysis with anti-UBE3A and -SK2 antibodies of immunoprecipitation performed with anti-UBE3A antibodies (+) or control IgG (−). SK2 is clearly co-immunoprecipitated with UBE3A in WT mice. Lower panel, immunoprecipitation was performed with anti-SK2 antibodies and Western blots were labelled with anti-UBE3A antibodies. UBE3A is co-immunoprecipitated with SK2 in WT mice and in AS mice albeit with reduced amount. * indicates non-specific bands in control IgG groups. Mol-M, molecular weight marker.

(C) Immunoprecipitation was performed with anti-SK2 antibodies and Western blots were labelled with anti-SK2 and -ubiquitin (Ub) antibodies. Arrows indicate ubiquitinated SK2 and/or SK2-associated proteins. Right panel, quantification of the relative abundance of ubiquitinated SK2 and/or SK2-associated proteins in hippocampus of WT and AS mice (means ± SEM, * p < 0.05, as compared to WT mice, n=3, Student's t test).

(D) Immunoprecipitation under denaturing conditions was performed with anti-SK2 antibodies or control IgG and Western blots were labelled with anti-ubiquitin antibodies. Arrows indicate ubiquitinated SK2. Right panel, quantification of the relative abundance of ubiquitinated SK2 in hippocampus of WT and AS mice (means ± SEM, *** p < 0.001, as compared to WT mice, n=3, Student's t test). See also Figure S2.

HHS Vulnerability Disclosure